ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemic

By sjmartinez • October 31, 2024

Keshtkar-Jahromi M, Anstrom KJ, Barkauskas C, Brown SM, Daar ES, Fischer W, Gibbs KW, Higgs ES, Hughes MD, Jagannathan P, LaVange L, Lindsell CJ, Nayak SU, Paredes R, Parmar M, Peltan ID, Proschan M, Shotwell MS, Vock DM, Yokum T, Adam SJ. ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemic. J Clin Transl Sci. 2024 Oct 15;8(1):e151. doi: 10.1017/cts.2024.1. PMID: 39478775; PMCID: PMC11523015.

Tags: ACTIV, Clinical Trial, covid-19, design, Infectious Diseases, lessons, Publications

Inflammation among kidney transplant donors with and without HIV: Multicenter HOPE in Action Consortium

Zaman F, Zhu X, Hunt JH, Rozek G, Eby Y, Hussain S, Desai NM, Florman S, Rana MM, Friedman-Moraco R, Pereira MR, Mehta S, Stock[...]

The life cycle of infection prevention and antimicrobial stewardship projects and interventions: the dynamic interplay of implementation and de-implementation science (Part I of II)

Branch-Elliman W, Chambers DA, Albin O, Batshon L, Castejon-Ramirez S, Cheng VC, Emetuche N, Datta R, Kamboj M, Krein SL, Staub M, Dassum SR, Rittmann[...]

Leveraging de-implementation science to promote infection prevention and stewardship: a roadmap and practical examples (Part II of II)

Branch-Elliman W, Reyes Dassum S, Stroever S, Albin O, Batshon L, Castejon-Ramirez S, Cheng VC, Emetuche N, Datta R, Kamboj M, Krein SL, Staub M,[...]